Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Synapse-associated protein 1 (SYAP1) is a BSD domain-containing adaptor protein that interacts with signaling partners such as Akt1, promoting phosphorylation of Akt1 at Ser477 in a process facilitated by mTORC2, and is involved in cellular response to growth factors including epidermal growth factor and peptide hormones[1][3]. This phosphorylation event is implicated in adipocyte differentiation by suppressing FoxC2 expression[1]. In mammals, SYAP1’s most prominent expression is within the nervous system, particularly in cerebellar Purkinje cells and cerebellar nuclei, as well as throughout regions rich in glutamatergic synapses[2]. Knockout mouse studies show that loss of SYAP1 results in distinct locomotor and motor adaptation defects, but does not affect basic metabolic parameters, cognition, or general viability. The gene is located on Xp22.2, a locus associated with neurodevelopmental disorders, with mutations in humans linked to developmental delay and autism spectrum[2][3]. Functionally, SYAP1 is not a receptor, enzyme, transporter, or classic drug target, but serves as a scaffold/adaptor implicated in signaling and neuronal function[1][2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Synapse-associated protein 1 (SYAP1).